The U.S. Food and Drug Administration on Tuesday extended the review of Merus NV's gene-targeting cancer therapy to allow ...
The FDA faces policy challenges as technological advances roil health care and the agency fights for resources from Congress — no matter who wins the election.
The FDA has scuttled Merus’ plans to win a speedy approval for i | The FDA has scuttled Merus’ plans to win a speedy approval ...
FDA is giving the food and beverage industry an additional two months to respond to its request that they slash sodium in ...
A range of bread products has been recalled and classified by the U.S. Food and Drug Administration (FDA) because of the presence of an unlabeled allergen. Aunt Millie's Bakehouse products produced by ...
Despite the PDUFA date being extended by three months for Merus’ zenocutuzumab, Truist Securities analyst Asthika ...
Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.
Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term ...
On October 30, 2024, the U.S. Food and Drug Administration’s (FDA) newly minted Human Foods Program (HFP) published a list of priority ...
MedPage Today on MSN1d
FDA Approves New Option for RosaceaShare on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...
Last month, the US Food and Drug Administration (FDA) approved three new drugs, as well as a potentially practice-changing ...
Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback